Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spray-Tek is a leading contract development and manufacturing organization (CDMO) specializing in spray drying and particle engineering for the pharmaceutical, nutraceutical, and food industries. Founded in 1980, the company operates state-of-the-art facilities in New Jersey and Pennsylvania, providing services ranging from pilot-scale R&D to high-volume commercial production. Their expertise includes microencapsulation, custom formulation, and the production of complex powder-based ingredients. Spray-Tek maintains rigorous quality standards, including GMP compliance and FDA registration, ensuring high-quality outputs for sensitive life science applications. In late 2022, the company was acquired by Barentz, a global life science ingredients distributor, to enhance its technical manufacturing capabilities in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spray-Tek.